KARO BIO AB

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
 
 
C07K PEPTIDES 2134
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8921402 Substituted pyrazoles as estrogen receptor ligandsJan 10, 14Dec 30, 14[C07D]
8710243 Estrogen receptor ligandsOct 06, 10Apr 29, 14[C07D]
8653112 Substituted pyrazoles as estrogen receptor ligandsOct 06, 10Feb 18, 14[A61K, C07D]
7342127 Substituted anilide ligands for the thyroid receptorJan 23, 04Mar 11, 08[A01N]
7109164 Aniline-derived ligands for the thyroid receptorAug 30, 04Sep 19, 06[C07C]
6800605 Aniline-derived ligands for the thyroid receptorJan 16, 01Oct 05, 04[C07C]
6228990 Estrogen receptor ligandsFeb 12, 99May 08, 01[C07K]
5958710 Orphan receptorMay 08, 97Sep 28, 99[C12N, G01N, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8124129 Crystalline form of the compound A-348441ExpiredJul 12, 06Feb 28, 12[A61K]
2011/0201,555 NOVEL ESTROGEN RECEPTOR LIGANDSAbandonedSep 18, 09Aug 18, 11[A61K, C07D, A61P]
7956214 Process for the preparation of aniline-derived thyroid receptor ligandsExpiredJun 15, 09Jun 07, 11[C07C]
2011/0112,142 NOVEL ESTROGEN RECEPTOR LIGANDSAbandonedApr 08, 09May 12, 11[A61K, C07D, A61P]
2011/0014,243 PHARMACEUTICAL COMPOSITIONSAbandonedDec 15, 08Jan 20, 11[A61K, A61P]
2010/0210,524 NOVEL ESTROGEN RECEPTOR LIGANDSAbandonedJul 21, 08Aug 19, 10[A61K, C07D, C07C, A61P]
2010/0004,271 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTORAbandonedJul 04, 06Jan 07, 10[A61K, C07D, G01N, A61P]
2009/0326,018 2-Phenyl indene derivatives useful as estrogen receptor ligandsAbandonedOct 12, 07Dec 31, 09[A61K, C07D, C07C]
2009/0318,514 Novel Pharmaceutical CompositionsAbandonedMay 03, 07Dec 24, 09[A61K, C07D, A61P]
2009/0239,951 Crystalline MaterialAbandonedMar 27, 07Sep 24, 09[A61K]
2009/0233,979 Indole Derivatives and Their Use as Thyroid Receptor LigandsAbandonedMay 24, 07Sep 17, 09[A61K, C07D]
2009/0220,598 Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor AgonistsAbandonedMar 27, 07Sep 03, 09[A61K]
7521439 Glucocorticoid receptor ligands for the treatment of metabolic disordersExpiredJul 21, 06Apr 21, 09[A61K]
2008/0221,210 Thyroid Receptor AgonistsAbandonedMar 22, 05Sep 11, 08[A61K, C07C, A61P]
2008/0058,383 Androgen Receptor ModulatorsAbandonedOct 21, 04Mar 06, 08[A61K, C07D, A61P]
2008/0027,096 Novel Pharmaceutical CompositionsAbandonedMar 04, 05Jan 31, 08[A61K, C07D, C07C, G01N, A61P]
7319096 Thyroid hormone receptor antagonists for cardiac and metabolic disorders IIExpiredApr 15, 02Jan 15, 08[A61K]
7319163 Thyroid receptor antagonists for the treatment of cardiac and metabolic disordersExpiredJun 24, 05Jan 15, 08[C07C]
2008/0004,251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid ReceptorAbandonedMar 22, 05Jan 03, 08[A61K, C07C, G01N, A61P]
7288571 Thyroid receptor ligands and method IIExpiredJul 26, 05Oct 30, 07[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.